| Active substance |
Tamoxifen Citrate
|
| Dosage |
20 Mg
|
| Water Retention |
No
|
| Hepatotoxicity |
Low
|
| Lab Test |
Blood estrogen levels
|
| Also known as |
Tamoxifen
|
| Blood pressure |
Generally does not affect blood pressure
|
| Trade name |
Nolvadex
|
| FORM |
Oral
|
| Dosage Unit |
Tabs
|
| ean13 |
1376170554735
|
| Reference |
HLM31
|
| Tab Piece |
50 Tabs
|
| Storage conditions |
Store at room temperature away from moisture and heat
|
| Chemical name |
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine
|
| Formula |
C26H29NO
|
| Substance class |
Selective Estrogen Receptor Modulator (SERM)
|
| Main action |
Antiestrogen
|
| Half-life |
5 to 7 days
|
| Dosage (medical) |
20 mg per day
|
| Dosage (sports) |
10-20 mg per day
|
| Effects |
Reduces estrogen binding to receptors, prevents gynecomastia, promotes a more favorable hormone balance for testosterone
|
| Side effects |
Hot flashes, vaginal dryness or discharge, mood swings, nausea, headache
|
| Use in sports |
Used to combat gynecomastia and improve the testosterone to estrogen ratio
|
| Packing |
Bottle
|
There are no reviews yet.